clear search
Search
Search Suggestions
Recent searches Clear History
Allergy & Autoimmune Disease
Allergy Solutions
ImmunoCAP Allergy Solutions
The gold standard in in-vitro allergy diagnostics with more than 500 whole allergens and allergen mixes.
Allergen Components
Food Allergies
Interpretation Guides
Respiratory Allergies
Product Catalog
Research & Customized Solutions
Specific IgE tests
Autoimmunity Solutions
EliA Autoimmunity Solutions
A high specificity and high sensitivity portfolio of more than 50 clinically relevant tests for autoimmune diseases.
Rheumatoid Arthritis
Connective Tissue Diseases
Celiac Disease
Thyroid Diseases
Vasculitis and Goodpasture Syndrome
Antiphospholipid Syndrome
Pernicious Anemia
Inflammatory Bowel Disease
Liver Diseases
Product Catalog
Polyautoimmunity
Systems
Phadia Laboratory Systems
Fully automated and scalable instruments to optimize allergy and autoimmune workflow.
Phadia 200
Phadia 250
Phadia 1000
Phadia 2500
Phadia 5000
Phadia Prime
Additional Services
Product Catalog
Resources
Center for Knowledge
Training, education, and service material for autoimmune and allergy testing.
All Resources
ImmunoSpotlight
Allergen Encyclopedia
Phadia Academy
Service & Support
Library
Lab Training
Thermo Fisher Scientific
visit thermofisher.com
Contact Us

Whole Allergen

f17 Hazelnut

f17 Hazelnut Scientific Information

Type:

Whole Allergen

Display Name:

Hazelnut

Route of Exposure:

Ingestion

Family:

Betulaceae (Corylaceae)

Species:

Corylus avellana

Latin Name:

Corylus avellana

Other Names:

European Hazel, Filbert, European filbert, giant filbert, Cob, Cobnut

Related Allergens: f440 Cor a 9, f428 Cor a 1, f439 Cor a 14, f425 Cor a 8

Summary

The hazel plant (Corylus avellana) is a native species of Europe and Western Asia which majorly contributes to the global production of hazelnuts. Upon ingestion, hazelnut may induce allergic reactions in two ways: as primary immunoglobulin E (IgE)-mediated food allergy or as oral allergy syndrome (OAS) associated with pollen allergy. It is the most common tree nut allergy in Europe. However, the prevalence of hazelnut allergy differs as a function of climate and age. Hazelnut allergy is considered as birch pollen-related in North-Western Europe, while it is considered to be pollen-unrelated allergy in Southern Europe. Primary sensitization to hazelnut occurs more often in children (<5 years) than in adults and predisposes to severe reactions, including anaphylaxis. As of February 9, 2021, 11 allergenic molecules have been identified, characterized and published officially by WHO/IUIS Allergen Nomenclature Sub-Committee for hazelnut. Among these 11 allergens, some are present in both hazel pollen and hazelnut (Cor a 1, Cor a 2, Cor a 6), some are present only in hazelnut (Cor a 8, Cor a 9, Cor a 11, Cor a 12, Cor a 13, Cor a 14, Cor a 15), and Cor a 10 is only found in hazel pollen. The OAS due to hazelnuts is mainly attributed to cross-reactivity between homologous allergens of hazelnut and birch pollens (Cor a 1 and Bet v 1, Cor a 2 and Bet v 2), while primary hazelnut allergy (gastrointestinal, respiratory or cardiovascular reactions, bronchospasms or even anaphylaxis) is attributed to thermostable allergens and storage proteins, such as Cor a 8, Cor a 9, Cor a 11 and Cor a 14. Furthermore, Cor a 14-IgE, followed by Cor a 9-IgE, serve as excellent diagnostic markers for identifying true hazelnut allergy and are often associated with severe symptoms. Hazelnut allergy may occur in association with other tree nut allergies, like peanut, walnuts, pecan, almond, cashew nuts, pistachio, macadamia, and Brazil nut.

Allergen

Nature

Corylus avellana, also referred to as hazel plant, is a species native to Europe and Western Asia and is considered as one of the most essential nut crops, available globally (1, 2). Hazelnut trees or shrubs are deciduous, diploid, monoecious, wind-pollinated and dichogamous species that can grow up to a height of 6 m. They have leaves with soft hairs on both sides. The flowers are monoecious with single-sex catkins: female catkins (bright-red, 1-3 mm long style) and male catkins (pale yellow, 5-12 cm long). The seed/nut/kernel is enclosed by a dark brown perisperm, which is protected by a woody rough shell. These nuts usually appear in clusters of 1-12, with each nut enclosed in a green leafy cover, that includes three-quarters of the nut (1).

It is generally consumed raw or roasted and is also included as a part of a large variety of processed food items, such as chocolate, creams, cakes, and confectionery products (2). 

Habitat

Hazelnut is a temperate nut crop that is widely distributed in the Northern Hemisphere, ranging from the Anatolian peninsula region and Caucasus region to Europe and North Africa. They usually grow at 40°–45° N latitude, and sometimes close to huge water bodies, such as the Mediterranean, Black, and Caspian seas (3). Hazelnut can even grow in contrasting conditions, like sunny as well as a shady environment. It requires highly fertile, nutrient-rich soil with slightly acidic or neutral pH and about 80-100 mm water for its finest growth. However, it can also survive on calcium-rich soil (3, 4).  

Taxonomy

The genus Corylus is mainly identified by its characteristic fruits that are large and contain an oil-rich seed in a brown pericarp (5). This genus consists of more than 14 varieties of hazelnuts, that are spread globally, according to the United States Department of Agriculture. All the Corylus spp. fruits are edible, however, Corylus avellana is the most extensively grown and consumed nut of hazel species (2). Besides Corylus avellana, other species of minor importance include C. americana, C. colurna, and C. heterophylla (3). 

Taxonomic tree of hazelnut, accessed on February 9, 2021  (6)

Taxonomic tree of Hazelnut  (6)  
Domain Eukaryota
Kingdom Plantae
Phylum Spemathophyta
Subphylum Angiospermae
Class Dicotyledonae
Order  Fagales
Family Betulaceae
Genus Corylus
Species Corylus Avellana
Taxonomic tree of Hazelnut  (6)  

Tissue

Hazelnut may induce allergic reactions on ingestion. It contains numerous allergenic molecules, with 11 currently listed by the World Health Organization and International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Subcommittee. Further, six of them, namely Cor a 1, Cor a 2, Cor a 8, Cor a 9, Cor a 11, and Cor a 14 are considered as the most relevant for human health (2, 7).

Epidemiology

Worldwide distribution

Hazelnut allergy can occur in two ways: as primary immunoglobulin E (IgE)-mediated food allergy or as oral allergy syndrome (OAS) associated with pollen allergy (pollen-food allergy syndrome, PFAS) (8). It is the most common tree nut allergy in Europe (9, 10). According to a systematic review, hazelnut allergy accounts for 17-100% of the total tree nut allergies in Europe (11). In a Europrevall study conducted in 6069 school children enrolled in birth cohorts from 8 European countries among, the overall prevalence of doctor-diagnosed hazelnut allergy was 1% (12). The Pronuts study, a prospective, multicenter, European study in London, Geneva and Valencia, reported  hazelnut allergy in 32% of nut-allergic individuals (n=122) (13).

However, the prevalence of hazelnut allergy differs as a function of climate and age. Hazelnut allergy is considered as birch pollen-related in North-Western Europe (Sweden, Germany, the Netherlands and Switzerland), while it is considered to be pollen-unrelated, mostly lipid transfer protein (LTP)-driven allergy in Southern Europe (2, 10, 14). A study conducted to assess the cross-sensitization profiles of tree nuts in birch-endemic areas in Finland found that the prevalence of hazelnut allergy among tree nut-allergic subjects, with and without birch sensitization, was 84% and 5%, respectively (15).

Furthermore, a prevalence study of probable food allergy (individuals having symptoms plus IgE sensitization) to 24 Europrevall priority foods in adults (20-54 years) (16) and school-age children (7-10 years) (17) across Europe was conducted. Probable hazelnut allergy, defined as the association of symptoms and confirmed sensitization, was markedly more common among adults and school children in Central and Northern countries (Zurich [Switzerland], Lodz [Poland], Utrecht [The Netherlands] and Vilnius [Lithuania]) than in Mediterranean countries (Madrid [Spain] and Athens [Greece]). However, in Central and Northern Europe adults were more often affected than children. The highest prevalence in adults was found in Zurich (2.57%), while that in school-age children was found in Vilnius (2.15%) (16, 17). Additionally, self-reported hazelnut allergy was present in 8.9% of adults from the Swedish general population in a cross-sectional survey (n=1042), and 5.3% exhibited both symptoms and hazelnut sensitzation (18).

The Danish Calmette study conducted on 1066 infants aged 13 months reported hazelnut sensitization in 1.2%, usually without associated symptoms (19). In Dutch patients displaying IgE to hazelnut, roughly 50% were confirmed as allergic (40/81 children and 39/80 adults) (20). A study conducted in 227 East Mediterranean children with tree nut/peanut allergy showed hazelnut to be the cause of allergy in 63.9% of children (21). Besides, hazelnut was responsible for allergic reactions in 22.4% of children with food allergy (n=912) and 14% of children with atopic dermatitis (n=1140) in a retrospective study conducted in Turkey. Hazelnut has been considered as a common nut allergy, ranking third among food allergies in Turkey (22).

Outside Europe and Mediterranean regions, hazelnut sensitization and allergy are also frequent. Two studies in the framework of Europrevall project reported the prevalence of hazelnut sensitization in 7.3% of patients in South India (n=588) (23) and the prevalence of hazelnut allergy in 0.09% of children in Tomsk, Russia (n=652)  (24). A prospective, single-center cohort study in Israel reported clinical allergy to hazelnut in 23% of tree nut-suspected allergic individuals (n=83) (25). The HealthNuts study performed in 3232 children (6 years) in Australia reported a prevalence of 0.9% for challenge-confirmed hazelnut allergy (26). In a cross-sectional, retrospective study conducted in Mexico, 49% of food-allergic individuals were found to be sensitized to hazelnut, a high prevalence attributed to oak tree pollen cross-sensitization (n=2633) (27). Another study conducted in 137 food-sensitized children from urban Cape Town, South Africa, found a 1.1% prevalence of hazelnut sensitization, however, none of the children were diagnosed with hazelnut allergy based on oral food challenge (OFC) (28).

Risk factors

Birch, hazel or alder pollinosis is associated with a higher risk of developing pollen-related hazelnut allergy (2). Further, individuals with filaggrin gene mutations are usually at higher risk of developing hazelnut allergy. Such individuals are predisposed to atopic dermatitis and may develop severe allergy due to early sensitization to the food allergen (29).

Pediatric issues

Primary sensitization to hazelnut occurs more often in children (<5 years) than in adults, and predisposes to severe reactions, including anaphylaxis (10, 20, 30, 31). 

Environmental Characteristics

Worldwide distribution

Globally, Western Asia and Europe have the major contribution (~89%) of the total production of hazelnuts (2, 3). Turkey being the largest producer of this nut, is followed by Italy, United States of America, Georgia, Azerbaijan and Spain (2, 3). Its cultivation has also extended towards the Southern Hemisphere, which includes Australia, Southern Africa and Chile (3).

Route of Exposure

Main

Oral ingestion of hazelnuts can trigger allergic reactions, with symptoms ranging from mild oral symptoms to very severe symptoms like bronchospasm or even anaphylaxis (32).

Secondary

In addition to ingestion, skin contact can also be a route of exposure, especially in atopic children, since hazelnut oil is used in several cosmetic products, like cream or bath oil (33).

Clinical Relevance

Oral allergy symptoms and Anaphylaxis

Hazelnut allergy is mainly IgE-mediated, however, it is manifested in two ways: primary hazelnut allergy and OAS related to pollens (10). Birch pollen-related hazelnut allergy is mainly observed in adults, manifesting mainly as OAS (symptoms limited to the oropharyngeal cavity), although systemic symptoms and even anaphylaxis have been infrequently reported. It is mainly attributed to cross-reactivity between homologous allergens of hazelnut and birch pollens (PR-10 proteins Cor a 1 and Bet v 1, profilins Cor a 2 and Bet v 2) (8, 10). Primary hazelnut allergy, however, is usually manifested as generalized symptoms (gastrointestinal, respiratory or cardiovascular reactions), which could be severe, leading to bronchospasm or even anaphylaxis. These reactions are attributed to thermostable allergens: the LTP Cor a 8 and the storage proteins Cor a 9, Cor a 11 and Cor a 14 (2, 10, 32).

Oral Allergy Syndrome (OAS) is very commonly observed in hazelnut-allergic patients with different rates of severity. This was observed in a study conducted on 731 patients from 12 European centers. Mild, moderate and severe allergic reactions were reported in 47.9%, 36% and 15.9% of patients, respectively (32). Furthermore, anaphylaxis was observed in 3% of patients (14).

A study was conducted on 24 Eastern Mediterranean hazelnut-allergic children who were confirmed as allergic based on a double-blind placebo-controlled food challenge (DBPCFC). The results reported allergic reactions, such as cutaneous, gastrointestinal, and respiratory reactions in 87.5%, 29.2% and 33.3% of patients, respectively. Anaphylactic reactions were observed in 41.6% of children. (34).

Further, a retrospective study conducted in Japan on 91 hazelnut-sensitized school children confirmed clinical allergy in 9 patients. The symptoms reported were skin and respiratory reactions in 44% of patients and gastrointestinal reactions in 100% of the allergic patients, while anaphylaxis was reported in 33% (35).

In the European Anaphylaxis Registry, which compiled the data of 1970 patients (<18 years), between the years 2007 to 2015, anaphylaxis due to hazelnut was reported in 76 patients, suspected in ten more, and was associated with 2 out of 17 most severe reactions, defined as grade III or higher (36).

Allergic rhinitis (AR) and allergic rhino-conjunctivitis (ARC)

Allergic rhinitis is not induced by hazelnut but can be associated with reactions to it. Allergic rhinitis was reported in 2 of 9 Japanese pediatric patients with challenge-confirmed allergy to hazelnut (35).

In a retrospective study conducted in the Netherlands, rhino-conjunctivitis was reported in 6% of adults during a DBPCFC conducted for hazelnut (30). In another retrospective study conducted in Japan, allergic conjunctivitis was reported in 22% of hazelnut-allergic patients (35).

Asthma

Bronchial asthma was reported in 33% of patients who reported clinical allergy to hazelnut in a study conducted in Japan (35). 

Atopic Dermatitis

Atopic dermatitis was frequently reported in a survey conducted on 731 hazelnut-allergic patients from 12 European centers. It was observed to be 20% in mild patients, 34% in moderate patients and 37% in severe patients (32). The Danish Calmette study conducted in Denmark reported atopic dermatitis in 61.5% of hazelnut-allergic infants (n=13) (19). Further, in a retrospective study conducted in Japan, atopic dermatitis was found to be 56% in patients who reported clinical allergy to hazelnuts (35).

Diagnostics Sensitization

Challenge test

Oral food challenge , especially DBPCFC, is considered as a gold standard for diagnosing allergy related to hazelnut. However, it is very time-consuming, expensive and related with risk of developing severe reactions (10, 37).

A study has documented that low-dose OFC in hazelnut-allergic children could be safe and effective, as it leads to only mild and localized allergic symptoms (9) . In addition, specific-IgE reactivity to Cor a 9 and Cor a 14 may also be useful in predicting the challenge outcomes. It is shown in a study that hazelnut-allergic patients (children as well as adults) with high specific-IgE levels to Cor a 9 and Cor a 14 have lower clinical thresholds to hazelnut and thus at more risk of developing severe reactions on a challenge (38).  

Prevention and Therapy

Allergen immunotherapy

Sublingual immunotherapy for hazelnut results in decreased sensitization in skin prick test (SPT) with higher levels of IgG4 and less systemic reactions. However, there is a paucity of evidence for its long-term safety and tolerability (39). A study was conducted to evaluate the efficacy and safety of low-dose hazelnut OFC in 43 patients with hazelnut allergy. The procedure showed 66% success rate and was observed to be effective in terms of improvement in the quality of life (9).

A retrospective single-center study evaluating 6-month oral allergen immunotherapy in 100 hazelnut-allergic children (<18 years), showed one-third of patients to be desensitized to hazelnut with adverse reaction reported in 30%. Whole hazelnut-IgE levels, small wheal diameter on SPT, absence of allergy to cashew and older age were strongly correlated with the efficiency of oral allergen immunotherapy (40).

Molecular Aspects

Allergen

Isoallergens

Biochemical Name

Molecular Weight (kDa)

Allergenicity

Cor a 1

Cor a 1.01

PR-10 protein

17
  • Major allergen (2).
  • Mild symptoms, manifested as OAS (2).
  • Positive IgE was observed in 73.2% of 423 food-allergic patients (14).
  • A sequence homology of 67% found with Bet v 1 (41).

Cor a 1.02

Cor a 1.03

Cor a 1.04

Cor a 2

Cor a 2.01

Profilin

14
  • Minor allergen (2).
  • Mild symptoms, manifested as OAS (2).
  • Positive IgE was observed in 19.6% of 423 food-allergic patients (14).

Cor a 6

Cor a 6.01

Isoflavone reductase homologue

35
  • Minor allergen (2).

Cor a 8

Cor a 8.01

Non-specific LTP type I

9
  • Major allergen (2)
  • Severe and systemic reactions (2).
  • Positive IgE was observed in 11.3% of 423 food-allergic patients (14).

Cor a 9

Cor a 9.01

11S legumin like globulin

40
  • Major allergen (2)
  • Severe and systemic reactions (2).
  • Positive IgE was observed in 10% of 423 food-allergic patients (14).

Cor a 10

Cor a 10.01

Luminal binding protein

70
  • Only present in pollens of hazel trees (2).

Cor a 11

 Cor a 11.01

7S vicilin like protein

48
  • Major allergen (2)
  • Severe and systemic reactions (2).
  • Positive IgE was observed in 3.5% of 423 food-allergic patients (14).

Cor a 12

Cor a 12.01

Oleosin

17
  • IgE prevalence of 63% has been reported (42).
  • Positive IgE was observed in 14.1% of 423 food-allergic patients (14).

Cor a 13

Cor a 13.01

Oleosin

14-16
  • IgE prevalence of 63% has been reported (42).

Cor a 14

Cor a 14.01

2S albumin

10
  • Minor allergen (2).
  • Moderate to severe symptoms (2).
  • IgE prevalence of 33% has been reported (42).
  • Positive IgE was observed in 6% of of 423 food-allergic patients (14).

Cor a 15

Cor a 15.01

Oleosin

17
  • Not available.

Allergen

Isoallergens

Biochemical Name

Molecular Weight (kDa)

Allergenicity

Compiled By

Author: Turacoz Healthcare Solutions

Reviewer: Dr. Christian Fischer

 

Last reviewed: March 2021

References
  1. Bottone A, Cerulli A, DʼUrso G, Masullo M, Montoro P, Napolitano A, et al. Plant Specialized Metabolites in Hazelnut (Corylus avellana) Kernel and Byproducts: An Update on Chemistry, Biological Activity, and Analytical Aspects. Planta medica. 2019;85(11-12):840-55.
  2. Costa J, Mafra I, Carrapatoso I, Oliveira MB. Hazelnut Allergens: Molecular Characterization, Detection, and Clinical Relevance. Critical reviews in food science and nutrition. 2016;56(15):2579-605.
  3. Silvestri C, Bacchetta L, Bellincontro A, Cristofori V. Advances in cultivar choice, hazelnut orchard management, and nut storage to enhance product quality and safety: an overview. J Sci Food Agric. 2020;101(1):27-43.
  4. Enescu C, Durrant T, de Rigo D, Caudullo G. Corylus avellana in Europe: distribution, habitat, usage and threats. 2016.
  5. Holstein N, Tamer S, Weigand M. The nutty world of hazel names – a critical taxonomic checklist of the genus Corylus (Betulaceae). European Journal of Taxonomy. 2018;409:1-45.
  6. CABI. Corylus avellana Wallingford, UK: CAB International; 2021 [updated November 18, 2019February 9, 2021]. Available from: https://www.cabi.org/isc/datasheet/17385.
  7. WHO/IUIS. "Corylus avellana - All Allergen": WHO/IUIS Allergen Nomenclature Sub-Committee; 2021 [updated January 16, 2020February 9, 2021]. Available from: http://www.allergen.org/search.php?Species=Corylus%20avellana.
  8. Ebo DG, Verweij MM, Sabato V, Hagendorens MM, Bridts CH, De Clerck LS. Hazelnut allergy: a multi-faced condition with demographic and geographic characteristics. Acta clinica Belgica. 2012;67(5):317-21.
  9. Barni S, Mori F, Piccorossi A, Sarti L, Pucci N, Maresca M, et al. Low-Dose Oral Food Challenge with Hazelnut: Efficacy and Tolerability in Children. International archives of allergy and immunology. 2019;178(1):97-100.
  10. Calamelli E, Trozzo A, Di Blasi E, Serra L, Bottau P. Hazelnut Allergy. Medicina (Kaunas, Lithuania). 2021;57(1).
  11. McWilliam V, Koplin J, Lodge C, Tang M, Dharmage S, Allen K. The Prevalence of Tree Nut Allergy: A Systematic Review. Current Allergy and Asthma Reports. 2015;15(9):54.
  12. Grabenhenrich L, Trendelenburg V, Bellach J, Yürek S, Reich A, Fiandor A, et al. Frequency of food allergy in school-aged children in eight European countries-The EuroPrevall-iFAAM birth cohort. Allergy. 2020;75(9):2294-308.
  13. Brough HA, Caubet JC, Mazon A, Haddad D, Bergmann MM, Wassenberg J, et al. Defining challenge-proven coexistent nut and sesame seed allergy: A prospective multicenter European study. The Journal of allergy and clinical immunology. 2020;145(4):1231-9.
  14. Datema MR, Zuidmeer-Jongejan L, Asero R, Barreales L, Belohlavkova S, de Blay F, et al. Hazelnut allergy across Europe dissected molecularly: A EuroPrevall outpatient clinic survey. The Journal of allergy and clinical immunology. 2015;136(2):382-91.
  15. Uotila R, Kukkonen AK, Pelkonen AS, Mäkelä MJ. Cross-sensitization profiles of edible nuts in a birch-endemic area. Allergy. 2016;71(4):514-21.
  16. Lyons SA, Burney PGJ, Ballmer-Weber BK, Fernandez-Rivas M, Barreales L, Clausen M, et al. Food Allergy in Adults: Substantial Variation in Prevalence and Causative Foods Across Europe. J Allergy Clin Immunol Pract. 2019;7(6):1920-8.e11.
  17. Lyons SA, Clausen M, Knulst AC, Ballmer-Weber BK, Fernandez-Rivas M, Barreales L, et al. Prevalence of Food Sensitization and Food Allergy in Children Across Europe. J Allergy Clin Immunol Pract. 2020;8(8):2736-46.e9.
  18. Rentzos G, Johanson L, Goksör E, Telemo E, Lundbäck B, Ekerljung L. Prevalence of food hypersensitivity in relation to IgE sensitisation to common food allergens among the general adult population in West Sweden. Clinical and translational allergy. 2019;9:22.
  19. Thøstesen LM, Kofoed PE. Allergic sensitization among Danish infants at 13 months of age. Immunity, inflammation and disease. 2019;7(3):183-90.
  20. Masthoff LJ, Mattsson L, Zuidmeer-Jongejan L, Lidholm J, Andersson K, Akkerdaas JH, et al. Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. The Journal of allergy and clinical immunology. 2013;132(2):393-9.
  21. Cetinkaya PG, Buyuktiryaki B, Soyer O, Sahiner UM, Sackesen C, Sekerel BE. Phenotypical characterization of tree nuts and peanut allergies in east Mediterranean children. Allergologia et immunopathologia. 2020;48(4):316-22.
  22. Kahveci M, Koken G, Şahiner Ü M, Soyer Ö, Şekerel BE. Immunoglobulin E-Mediated Food Allergies Differ in East Mediterranean Children Aged 0-2 Years. International archives of allergy and immunology. 2020;181(5):365-74.
  23. Mahesh PA, Wong GW, Ogorodova L, Potts J, Leung TF, Fedorova O, et al. Prevalence of food sensitization and probable food allergy among adults in India: the EuroPrevall INCO study. Allergy. 2016;71(7):1010-9.
  24. Fedorova OS, Ogorodova LM, Fedotova MM, Evdokimova TA. [The prevalence of food allergy to peanut and hazelnut in children in Tomsk Region]. Voprosy pitaniia. 2014;83(1):48-54.
  25. Elizur A, Appel MY, Nachshon L, Levy MB, Epstein-Rigbi N, Golobov K, et al. NUT Co Reactivity - ACquiring Knowledge for Elimination Recommendations (NUT CRACKER) study. Allergy. 2018;73(3):593-601.
  26. McWilliam V, Peters R, Tang MLK, Dharmage S, Ponsonby AL, Gurrin L, et al. Patterns of tree nut sensitization and allergy in the first 6 years of life in a population-based cohort. The Journal of allergy and clinical immunology. 2019;143(2):644-50.e5.
  27. Ruiz Segura LT, Figueroa Pérez E, Nowak-Wegrzyn A, Siepmann T, Larenas-Linnemann D. Food allergen sensitization patterns in a large allergic population in Mexico. Allergologia et immunopathologia. 2020:In press.
  28. Botha M, Basera W, Facey-Thomas HE, Gaunt B, Gray CL, Ramjith J, et al. Rural and urban food allergy prevalence from the South African Food Allergy (SAFFA) study. The Journal of allergy and clinical immunology. 2019;143(2):662-8.e2.
  29. Astolfi A, Cipriani F, Messelodi D, De Luca M, Indio V, Di Chiara C, et al. Filaggrin Loss-of-Function Mutations Are Risk Factors for Severe Food Allergy in Children with Atopic Dermatitis. Journal of clinical medicine. 2021;10(2).
  30. Masthoff LJ, van Hoffen E, de Reus A, Boonacker CW, Bruijnzeel-Koomen CA, Pasmans SG, et al. Hazelnut allergy differs between children and adults in frequency of severity, aetiology and relevance of diagnostic parameters. Clin Exp Allergy. 2014;44(12):1539-45.
  31. Valcour A, Lidholm J, Borres MP, Hamilton RG. Sensitization profiles to hazelnut allergens across the United States. Ann Allergy Asthma Immunol. 2019;122(1):111-6.e1.
  32. Datema MR, van Ree R, Asero R, Barreales L, Belohlavkova S, de Blay F, et al. Component-resolved diagnosis and beyond: Multivariable regression models to predict severity of hazelnut allergy. Allergy. 2018;73(3):549-59.
  33. Verweij MM, Hagendorens MM, De Knop KJ, Bridts CH, De Clerck LS, Stevens WJ, et al. Young infants with atopic dermatitis can display sensitization to Cor a 9, an 11S legumin-like seed-storage protein from hazelnut (Corylus avellana). Pediatr Allergy Immunol. 2011;22(2):196-201.
  34. Buyuktiryaki B, Cavkaytar O, Sahiner UM, Yilmaz EA, Yavuz ST, Soyer O, et al. Cor a 14, Hazelnut-Specific IgE, and SPT as a Reliable Tool in Hazelnut Allergy Diagnosis in Eastern Mediterranean Children. J Allergy Clin Immunol Pract. 2016;4(2):265-72.e3.
  35. Inoue Y, Sato S, Takahashi K, Yanagida N, Yamamoto H, Shimizu N, et al. Component-resolved diagnostics can be useful for identifying hazelnut allergy in Japanese children. Allergology international : official journal of the Japanese Society of Allergology. 2020;69(2):239-45.
  36. Grabenhenrich LB, Dölle S, Moneret-Vautrin A, Köhli A, Lange L, Spindler T, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. The Journal of allergy and clinical immunology. 2016;137(4):1128-37.e1.
  37. Eller E, Mortz CG, Bindslev-Jensen C. Cor a 14 is the superior serological marker for hazelnut allergy in children, independent of concomitant peanut allergy. Allergy. 2016;71(4):556-62.
  38. Masthoff LJN, Blom WM, Rubingh CM, Klemans RJB, Remington BC, Bruijnzeel-Koomen C, et al. Sensitization to Cor a 9 or Cor a 14 has a strong impact on the distribution of thresholds to hazelnut. J Allergy Clin Immunol Pract. 2018;6(6):2112-4.e1.
  39. Wai CYY, Leung NYH, Leung PSC, Chu KH. Immunotherapy of Food Allergy: a Comprehensive Review. Clinical reviews in allergy & immunology. 2019;57(1):55-73.
  40. Moraly T, Pelletier de Chambure D, Verdun S, Preda C, Seynave M, Vilain AC, et al. Oral Immunotherapy for Hazelnut Allergy: A Single-Center Retrospective Study on 100 Patients. J Allergy Clin Immunol Pract. 2020;8(2):704-9.e4.
  41. Blankestijn MA, Knulst AC, Knol EF, Le TM, Rockmann H, Otten HG, et al. Sensitization to PR-10 proteins is indicative of distinctive sensitization patterns in adults with a suspected food allergy. Clinical and translational allergy. 2017;7:42.
  42. Scala E, Asero R, Niederberger V. Tree Pollen Allergy. In: Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, Valenta R, Ollert M, editors. EAACI Molecular Allergology User's Guide: Using Molecular Allergology in the Clinical Practice. Zutich, Switzerland: The European Academy of Allergy and Clinical Immunology (EAACI); 2016. p. 71-83.
  43. Uotila R, Röntynen P, Pelkonen AS, Voutilainen H, Kaarina Kukkonen A, Mäkelä MJ. For hazelnut allergy, component testing of Cor a 9 and Cor a 14 is relevant also in birch-endemic areas. Allergy. 2020;75(11):2977-80.
  44. Masthoff LJ, van Hoffen E, Mattsson L, Lidholm J, Andersson K, Zuidmeer-Jongejan L, et al. Peanut allergy is common among hazelnut-sensitized subjects but is not primarily the result of IgE cross-reactivity. Allergy. 2015;70(3):265-74.
  45. Masthoff LJN, Pasmans S, van Doorn H, den Hartog Jager CF, Geneugelijk K, Knol EF, et al. Major hazelnut and peanut allergens are potent in basophil activation and cross-react at T-cell level. Allergy. 2018a;73(10):2080-2.
  46. Villalta D, Scala E, Mistrello G, Amato S, Asero R. Evidence of Cross-Reactivity between Different Seed Storage Proteins from Hazelnut (Corylus avellana) and Walnut (Juglans regia) Using Recombinant Allergen Proteins. International archives of allergy and immunology. 2019;178(1):89-92.
  47. Elizur A, Appel MY, Nachshon L, Levy MB, Epstein-Rigbi N, Pontoppidan B, et al. Walnut oral immunotherapy for desensitisation of walnut and additional tree nut allergies (Nut CRACKER): a single-centre, prospective cohort study. The Lancet Child & adolescent health. 2019;3(5):312-21.
  48. Bastiaan-Net S, Batstra MR, Aazamy N, Savelkoul HFJ, van der Valk JPM, Gerth van Wijk R, et al. IgE cross-reactivity measurement of cashew nut, hazelnut and peanut using a novel IMMULITE inhibition method. Clin Chem Lab Med. 2020;58(11):1875-83.
  49. van Odijk J, Sjölander S, Brostedt P, Borres MP, Englund H. High frequency of IgE sensitization towards kiwi seed storage proteins among peanut allergic individuals also reporting allergy to kiwi. Clin Mol Allergy. 2017;15:18.